A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers

Clinical trial NCT05851066 · COMPLETED

Trial details

NCT number: NCT05851066
Sponsor: Visirna Therapeutics HK Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dyslipidemias Familial Hypercholesterolemia Hypertriglyceridemia

Start date: 2023-06-01
Primary completion: 2024-05-07
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.